EGFR MUTATION
Clinical trials for EGFR MUTATION explained in plain language.
Never miss a new study
Get alerted when new EGFR MUTATION trials appear
Sign up with your email to follow new studies for EGFR MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Brain vs. body: new trial tests stronger drug dose against Drug-Chemo combo for tough lung cancer
Disease control Not yet recruitingThis study aims to find the better first treatment for people with a specific type of lung cancer (EGFR-mutated NSCLC) that has spread to the brain. It will compare a higher dose of the targeted drug furmonertinib taken alone against a lower dose of the same drug combined with tw…
Matched conditions: EGFR MUTATION
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New drug duo aims to outsmart resistant lung cancer
Disease control Not yet recruitingThis study is testing a new two-drug combination for people with a specific type of advanced lung cancer that has spread. The goal is to find a safe dose and see if the combination can help shrink tumors or stop them from growing. The trial is for adults whose cancer has a geneti…
Matched conditions: EGFR MUTATION
Phase: PHASE1, PHASE2 • Sponsor: Beijing Pearl Biotechnology Limited Liability Company • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC